期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 15, 期 6, 页码 202-206出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2005.07.002
关键词
-
Over the past decade, a large number of studies reported a prominent role of inflammation therapeutic strategies to reported a prominent atherosclerosis. Thus, reduce inflammation could exert beneficial effects in the prevention of atherosclerosis progression. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) have demonstrated their capacity to greatly reduce coronary morbidity and mortality in both primary and secondary intervention trials. Furthermore, originally described as the most efficient drugs to reduce serum cholesterol, recent reports suggest that statins also confer cardiovascular benefits by their ability to modulate immuno-inflammatory processes. This review summarizes in vitro and in vivo evidence of immunomodulatory properties of statins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据